Meet Omnipod® 5
- Automated insulin delivery helps to keep you in range, day and night1,2
- No multiple daily injections, insulin pump tubing or finger pricks‡
- Share the load with a system that’s always adjusting, so you don’t have to
- Suitable for people with type 1 diabetes ages 2 years and older
- Integrates with the Dexcom G6 sensor and the FreeStyle Libre 2 Plus sensor
Omnipod 5 is an automated insulin delivery (AID) system, which you may know as a hybrid closed loop system. Working day and night to keep you in range, it now integrates with your choice of the Dexcom G6 sensor or the FreeStyle Libre 2 Plus sensor.
Fuel your freedom with a system that delivers automated insulin adjustments every five minutes, responding to predicted glucose levels by automatically increasing, decreasing or pausing insulin delivery depending on whether glucose levels are rising or falling.
One System.
Designed to Deliver.
With Omnipod 5, there’s no need to choose between the precision of an Automated Insulin Delivery System and the freedom of a tubeless device.
More time in range1
Lower A1C1
Adapting to you
3 Simple Parts
To enjoy Automated Insulin Delivery with the Omnipod® 5 System
The Omnipod 5 Controller
Take control of the system with the Omnipod 5 Controller. Monitor and control the Pod's operations using Bluetooth® wireless technology.
The Pod
Tubeless, wearable, and waterproof**, the Pod, with built-in SmartAdjust™ technology, sits on the body and automatically adjusts insulin delivery for up to 3 days or 72 hours.
The Sensor
Continuously sends glucose values to the Pod, so you can get real-time data† without the finger pricks‡. The Dexcom G6 and FreeStyle Libre 2 Plus sensors are sold separately and require a separate prescription§.
The Pod and sensor need to be in ‘line of sight’ to stay in Automated Mode. Placing them on the same side of the body allows for best communication between the devices.
Using our SmartAdjust™ technology, Omnipod 5 and the sensor are in constant communication. This enables automated insulin delivery, freeing you from manually controlling your insulin around the clock. Less work for you, more time in range1,2.
You will still need to bolus for meals and correction doses through the Omnipod 5 Controller, where you monitor and control the Pod's operations using Bluetooth® wireless technology.
Innovation at your fingertips
Omnipod 5 boasts outstanding design and engineering, recognized by the Consumer Electronics Show (CES) Innovation Awards, in the US, in 2022.
Don’t just take our word for it…
Here’s what our Podders® have to say about Omnipod 5:
“Omnipod 5 has allowed me to get a good night’s rest. That’s the first time I can say that in a long time. I love it.”
Alvin M
“I love automated insulin delivery, I can do things a lot more spontaneously. My parents would say it’s been a life-changer for me AND for them.”
Mattie G
“With Omnipod 5, I’ve found a new confidence that I didn’t have before… I’m almost a new person. Omnipod 5 makes me feel safe.”
Morgan M
We believe in freedom of choice!
At Insulet, we believe those who have been deemed eligible for pump therapy should have the freedom to choose and the flexibility to change insulin delivery devices with no ‘lock-in’ periods.
Are you new to pump therapy, or considering switching to a different insulin pump? Find out more about how our commitment to choice may help you.
Get started with one of these options
Try a Sample Pod§ At Home Today!
The Pod Experience Kit* contains a real-size, real-weight demo Pod*, without the insulin.
It’s designed to give you an idea of what it feels like to wear a Pod, and get a sense of how discreet it can be.
Talk to an Omnipod® Specialist
Still have more questions about the Omnipod® System? Enter your information below and one of our Omnipod® Specialists will call you in 24-48 hours for a one-to-one chat. Or you can call us direct at 0800 011 6132* (option 4) or +44 20 3887 1709 (option 4) if calling from abroad.
Try the Omnipod 5 Simulator App
Try a simulated version of the Omnipod 5 Controller for yourself with the Omnipod 5 Simulator App.
The demo screens are just like the real Controller‡, giving you an overview of just how simple the system is to use. They’re a great tool for the virtual demo, too!
Join an Omnipod Live Demo
Considering Pod Therapy with Omnipod?
Register for a free virtual live demo to see Omnipod 5 in action. The 60 minute session includes an overview of Pod Therapy and a walk-through of everything from activating a Pod to delivering an insulin bolus.
Looking for more information
about Omnipod 5?
Check out the Omnipod 5 FAQs, “How to” video tutorials or Request a call
‡ Finger pricks required for diabetes treatment decisions if symptoms or expectations do not match readings.
**The Pod has an IP28 rating for up to 7.6 metres (25 feet) for 60 minutes. The Omnipod 5 Controller is not waterproof. Please refer to sensor manufacturer user guide for sensor waterproof rating.
† Shah VN, et al. Diabetes Technol and Ther. 2018;20(6).
‡ Finger pricks required for diabetes treatment decisions if symptoms or expectations do not match readings.
§ The Dexcom G6 sensor must be used with the Dexcom G6 App. The Dexcom G6 receiver is not compatible with Omnipod 5. The FreeStyle Libre 2 Plus sensor cannot be used with the LibreLink App, LibreView App and LibreLinkUp App, and it must be started with the Omnipod 5 App only.
Pod, Dexcom G6 and FreeStyle Libre 2 Plus shown without necessary adhesive.
1.Study in 240 people with T1D aged 6 - 70 years involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average day time (6AM-12AM) in Target Glucose range (from CGM) in adults/adolescents and children for standard therapy vs Omnipod 5 = 64.8% vs. 72.5%; 51.5% vs. 64.6%. Average overnight (12AM-6AM) in Target Glucose range (from CGM) in adults/adolescents and children for standard therapy vs Omnipod 5 = 64.3% vs. 78.1%; 55.3% vs. 78.1%. Average A1c in adults/adolescents and children, standard therapy vs. Omnipod 5 = 7.16% vs 6.78%; 7.67% vs 6.99%. Brown et al. Diabetes Care (2021).
2. Study in 80 people with T1D aged 2 - 5.9 yrs involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time in Target Glucose range (6AM-12AM) from CGM in standard therapy vs Omnipod 5 = 58.2% vs. 64.3%. Average time in Target Glucose range (12AM-6AM) from CGM in standard therapy vs. Omnipod 5 = 60.6% vs 82.4%. Average A1c in standard therapy vs. Omnipod 5 = 7.4% vs. 6.9%. Sherr JL, et al. Diabetes Care (2022).